Personalis, Inc. Earnings Per Share, Basic and Diluted
Personalis, Inc. (PSNL) reported Earnings Per Share, Basic and Diluted of -$0.63 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- Personalis, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.63.
- Personalis, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.40.
- Personalis, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.34.
- Personalis, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.29.
- Personalis, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.49.
- Personalis, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.20.
- Personalis, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.39.
- Personalis, Inc. earnings per share, basic and diluted for fiscal 2018 was -$6.49.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.63 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | -$1.49 10-K · filed 2022-02-24 | |||
| 2021-09-30 | -$0.40 10-Q · filed 2021-11-04 | -$1.03 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | -$0.34 10-Q · filed 2021-08-04 | -$0.63 10-Q · filed 2021-08-04 | ||
| 2021-03-31 | -$0.29 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.62 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.91 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.20 10-K · filed 2022-02-24 |
| 2020-09-30 | -$0.27 10-Q · filed 2021-11-04 | -$0.56 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.85 10-Q · filed 2021-11-04 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-06-30 | -$0.29 10-Q · filed 2021-08-04 | -$0.58 10-Q · filed 2021-08-04 | -$0.80 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.02 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-03-31 | -$0.29 10-Q · filed 2021-05-05 | -$0.50 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.73 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2019-12-31 | -$0.21 10-K · filed 2020-03-25 | -$0.43 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$0.84 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.39 10-K · filed 2022-02-24 |
| 2019-09-30 | -$0.22 10-Q · filed 2020-11-05 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$1.35 10-Q · filed 2020-11-05 | -$2.00 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-06-30 | -$0.89 10-Q · filed 2020-08-06 | -$2.38 10-Q · filed 2020-08-06 | -$3.55 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.74 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-03-31 | -$1.84 10-Q · filed 2020-05-07 | -$3.00 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.19 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$6.58 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2018-12-31 | -$1.16 10-K · filed 2020-03-25 | -$2.35 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.74 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$6.49 10-K · filed 2021-02-25 |
| 2018-09-30 | -$1.19 10-K · filed 2020-03-25 | -$3.58 derived: net income ÷ weighted average shares · filed 2019-11-13 | -$5.33 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$2.39 10-K · filed 2020-03-25 | -$4.15 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | -$1.76 10-K · filed 2020-03-25 | |||
| 2017-12-31 | -$7.78 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |